ZEB1 and in situ carcinoma: Moreover, because ZEB1 has been associated with chemoresistance in ovarian cancer39,40, we analyzed the anti-metastatic effect of macitentan in cisplatinum sensitive (A2780) or resistant (A2780 CIS) xenografts that overexpressed ETAR (Supplementary Fig. 6a).